Injectables Tomorrow: Subcutaneous DMPA and Home Injection
Tags: CONTRACEPTIVE drugs, Injectable; MEDROXYPROGESTERONE; CONTRACEPTIVE drugs; BIRTH control; WOMEN -- Health
Related Articles
- Depo-Provera: An injectable contraceptive. Earl, Daniel Thad; David, Daniel J. // American Family Physician;3/1/1994, Vol. 49 Issue 4, p891
Discusses the use of medroxyprogesterone acetate (Depo-Provera) as an injectable contraceptive. Indications and advantages; Dosage and administration; Contraindications; Side effects; Case studies on the use of the drug. INSET: Depo-provera--an injectable contraceptive..
- Just shoot me. Lee, Kendra // Heart & Soul;Nov99, Vol. 6 Issue 5, p26
Features Lunelle, a once-a-month injectable contraceptive for women. Determination of effectiveness in a study conducted at the University of Florida Health Science Center; Lunelle as a combination of progesterone and estrogen; Absence of significant side effects; Possible availability of...
- BIRTH CONTROL ALERT. Lumière, Erica // Glamour;Jan2003, Vol. 101 Issue 1, p53
Presents news briefs pertaining to contraceptives for women. Results a study on the safety of birth-control agent Depo-Provera for long-term users; Recall of 800,000 doses of the injectable contraceptive Lunelle.
- Characteristics of Injectable Contraceptive Users In a Low-Income Population in Texas. Sangi-Haghpeykar, Haleh; Poindexter 3rd, Alfred N.; Moseley, Deana C.; Bateman, Louise; Reid, Eladio D. // Family Planning Perspectives;Sep/Oct95, Vol. 27 Issue 5, p208
Among 600 women at 17 family planning clinics in Texas who expressed interest in using the hormonal injectable depot medroxyprogesterone acetate (DMPA), 536 (89%) actually received the injectable. Thirty percent of the DMPA recipients were younger than 21 and 77% were not married. The average...
- Risk of Cervical Cancer May Be Slightly Elevated for Users of Injectables. Donovan, P. // Family Planning Perspectives;Jul/Aug95, Vol. 27 Issue 4, p183
The article presents a discussion on the result of the data gathered by the World Health Organization stating the relation of using injectable contraceptives cancer risks. The study was conducted to investigate on the connection between injectable contraceptive, depot medoxyprogesterone...
- Progestin-Only Injectables. // Population Reports;Jun2008 Supplement, Issue 17, p3
The article discusses findings of a 2008 research which concluded that a woman could have a depot medroxyprogesterone acetate (DMPA) reinjection up to four weeks late without risk that she may possibly be pregnant. Previously, the recommended grace period for DMPA reinjection is two weeks. Women...
- Birth Control That Raises the Risk of HIV? Park, Alice // Time;10/17/2011, Vol. 178 Issue 15, p21
The article focuses on a study that shows using an injectable form of hormonal birth control may double a woman's risk of contracting the human immunodeficiency virus (HIV).
- STAY IN CONTROL. // Joe Weider's Muscle & Fitness;Aug2000, Vol. 61 Issue 8, p42
Offers a look at several products that help prevent pregnancy. Introduction of a skin-patch contraceptive; Information on Lunelle, an injectable contraceptive; Card that reminds women to take their pills offered by Organon Inc.
- Birth Control That Raises the Risk of HIV? Park, Alice // Time International (Atlantic Edition);10/17/2011, Vol. 178 Issue 15, p17
The article focuses on a study that shows using an injectable form of hormonal birth control may double a woman's risk of contracting the human immunodeficiency virus (HIV).
